Tricuspid atresia is a rare heart defect present at birth, and in tricuspid atresia the valve between the right upper and lower heart chambers does not form normally. Babies with tricuspid atresia often have blue or gray-looking skin, trouble feeding, fast breathing, and poor weight gain because blood flow to the lungs is reduced. The condition is lifelong, is usually recognized before birth or soon after delivery, and early signs of tricuspid atresia may vary depending on how well blood can reach the lungs. Not everyone will have the same experience. Treatment usually involves medicines and staged heart surgery in infancy and childhood, and while tricuspid atresia can be life-threatening without care, many children now survive into adulthood with specialist treatment.
How many people live with Tricuspid atresia?
Tricuspid atresia is one type of heart defect present at birth, and the best available counts usually come from that larger group: about 13 million people worldwide were living with congenital heart disease (Global Burden of Disease Study, 2019), and because tricuspid atresia makes up about 1% to 3% of these cases, this suggests roughly 130,000 to 390,000 people worldwide live with tricuspid atresia, although that is an estimate rather than a direct count. In the United States, about 2.4 million children and adults were living with congenital heart defects (CDC, 2024), which suggests roughly 24,000 to 72,000 people living with tricuspid atresia, again as an estimate rather than a direct count.
Overview
Tricuspid atresiaSymptoms
Tricuspid atresia is present at birth and often causes bluish skin or lips, fast breathing, poor feeding, and tiring easily. Some babies also have a heart murmur and slow weight gain.
Outlook and prognosis
With tricuspid atresia, outlook depends on heart structure, blood flow, and how well surgery supports circulation. Many children now reach adulthood, though lifelong heart follow-up is usually needed. Some may tire easily or need more treatment later.
Causes and risk factors
Tricuspid atresia happens before birth when the tricuspid valve does not form normally. The cause is usually unknown. Risk may be higher with certain genetic changes, a family history of heart defects, diabetes, or some pregnancy exposures.
Genetic influences
Genetics can play a role in tricuspid atresia, but most cases are not traced to a single inherited gene change. Rarely, genetic variations or chromosome differences are involved, especially when tricuspid atresia happens with other birth differences.
Diagnosis
Tricuspid atresia is usually diagnosed from clinical features and imaging findings, especially echocardiography. Some cases are found before birth on prenatal ultrasound. Genetic tests may be offered to look for related chromosome or syndrome changes.
Treatment and drugs
Treatment for Tricuspid atresia usually involves staged heart surgeries in infancy to improve blood flow, along with medicines that help the heart and lungs work more smoothly. Many living with Tricuspid atresia also need regular follow-up with a congenital heart specialist.
Symptoms
Babies with tricuspid atresia often show signs of low oxygen and extra strain on the heart soon after birth. Early on, this might look like bluish skin, fast breathing, or tiring during feeds. The early features of tricuspid atresia can be mild or more obvious, depending on how blood is moving through the heart.
The lips, tongue, or fingertips may look blue or gray because the blood is not carrying enough oxygen. This is often easiest to notice during crying, feeding, or when a baby is cold.
Babies with tricuspid atresia often breathe quickly or seem to work harder to breathe, even at rest. Feeding or crying can make this more noticeable because the body needs more oxygen.
Sucking and swallowing can be tiring, so feeds may take a long time or need frequent breaks. Some babies stop before finishing or seem short of breath while eating.
Poor feeding and the heart's extra workload can make weight gain slower than expected. In daily life, this may mean smaller feeds, longer feeds, and closer weight checks.
How people usually first notice Tricuspid atresia?
Tricuspid atresia is usually first noticed very early, often during a prenatal ultrasound or soon after birth when a baby looks blue or gray around the lips and skin because not enough blood is reaching the lungs for oxygen. The first signs of tricuspid atresia can also include fast breathing, trouble feeding, unusual sleepiness, or poor weight gain in the first days or weeks of life. In many babies, doctors hear a heart murmur or find low oxygen levels during a routine newborn check, which is often how tricuspid atresia is first recognized.
Types of Tricuspid atresia
Daily life with tricuspid atresia can look quite different from one child to another. This heart defect has a few recognized clinical variants, mainly based on how the major blood vessels are arranged and how much blood can reach the lungs, and those differences can affect how early symptoms appear and how severe they are. In practice, the types of tricuspid atresia help explain why some babies turn blue soon after birth, while others are noticed more because of fast breathing, poor feeding, or slower weight gain. Not everyone will experience every type in the same way.
Type I
In Type I tricuspid atresia, the major blood vessels are in their usual positions, but blood flow to the lungs may be too low or sometimes too high depending on the rest of the heart’s structure. Many babies with lower lung blood flow develop cyanosis, meaning a bluish color of the lips or skin, quite early. If lung blood flow is higher, breathing trouble and poor feeding may stand out more than blue coloring.
Type II
In Type II tricuspid atresia, the major blood vessels are switched, a pattern also called transposition of the great arteries. Symptoms can appear early and may include marked cyanosis, rapid breathing, sweating with feeds, and signs of heart failure if too much blood reaches the lungs. The balance of symptoms can shift over time as blood flow changes or as treatment is planned.
Type III
In Type III tricuspid atresia, other less common vessel arrangements or related heart differences are present. Symptoms vary more in this group, but babies may have a mix of blue coloring, tired feeding, poor growth, and breathing problems. Even within the same type, intensity can range from mild to severe.
Can I slow down the onset of symptoms?
No, not in a meaningful way: tricuspid atresia is a heart problem that develops before birth, so there is no good evidence that diet, exercise, sleep, or other lifestyle steps can delay when symptoms begin. Symptoms often start before birth or soon after delivery, and while early diagnosis during pregnancy or right after birth helps the care team plan medicines, monitoring, and surgery, that improves care rather than preventing or delaying the condition itself. The most helpful step is early specialist care, which can make a real difference in how well a baby does even though it cannot stop the condition from starting.
What genetics can tell you about symptoms
Genetics can sometimes help explain why tricuspid atresia happens as part of a broader genetic syndrome or alongside other birth differences, but in many children there is no single gene change that clearly predicts the exact symptoms. Most day-to-day symptoms are shaped more by how the heart formed, how well blood flows to the lungs and body, and whether there are other heart differences present, so severity and timing can vary a lot from one child to another. In short, genetics may offer clues about related conditions and overall risk, but it usually cannot precisely tell which symptoms will appear, how severe they will be, or when they will start.
Causes and risk factors
Tricuspid atresia starts early in pregnancy, when inherited or new genetic changes disrupt how the right side of the heart develops. When families ask what causes tricuspid atresia, there is often no single clear reason. Some risks are written in our DNA, passed down through families, and risk is higher with a family history of heart defects or a chromosome condition such as Down syndrome. Biological and environmental factors in pregnancy may modify risk, especially diabetes that is not well controlled or infections such as rubella. Alcohol, smoking, and some medicines during pregnancy can increase the chance of tricuspid atresia, although many babies with this condition are born without any known risk factor.
What are the most common causes or risk factors?
Tricuspid atresia starts very early in pregnancy, when the valve that should form between two right-sided heart chambers does not develop, and in many babies the exact reason is never known. The chance can be higher if there is a family history of a heart problem present at birth or if the baby has a genetic or chromosome condition that affects development. Some pregnancy-related factors can also raise the risk of heart birth defects, including poorly controlled diabetes, rubella infection, and exposure to alcohol, smoking, or certain medicines early in pregnancy.
Environmental and biological risk factors
When people ask about risk factors for tricuspid atresia during pregnancy, the honest answer is that several factors may play a part, but many cases still happen without a clear cause. Doctors often group risks into internal (biological) and external (environmental). Most known risks affect very early heart development, often before someone knows they are pregnant.
Poorly controlled diabetes before pregnancy or in the first weeks of pregnancy can raise the chance of tricuspid atresia and other heart differences present at birth. Careful blood sugar control before conception and early in pregnancy may help lower that risk.
Some infections during pregnancy, especially rubella, can interfere with normal heart development in the baby. A significant fever early in pregnancy may also add to the risk.
A small number of medicines taken in early pregnancy are known to increase the chance of congenital heart defects. Examples include isotretinoin, lithium, and some seizure medicines, which is why a medication review before or early in pregnancy is important.
High-dose radiation during pregnancy can disturb early organ formation, including the heart. This is uncommon, but doctors consider it when looking at possible environmental risks.
Genetic risk factors
Many families want to know why tricuspid atresia happened. In most babies, doctors cannot find one single inherited cause, even though genes can still be involved. The genetic causes of tricuspid atresia may include chromosome differences, rare gene changes, or a family tendency toward congenital heart defects. Carrying a genetic change doesn’t guarantee the condition will appear.
Family history: Having a parent, sibling, or previous child with a congenital heart defect can raise the chance of tricuspid atresia in a future pregnancy. The increase is usually still small, but it is higher than in families with no history of heart defects.
Chromosome changes: Some babies have extra, missing, or rearranged chromosome material. These chromosome differences can disrupt early heart development and sometimes also affect growth or other organs.
Genetic syndromes: Tricuspid atresia can be one feature of a broader genetic syndrome. This is more likely when there are other birth differences, developmental delays, or health problems alongside the heart condition.
Rare gene changes: Rare changes in genes that guide early heart formation have been found in some families and some individual children. These changes may be inherited from a parent or may arise for the first time in the child.
Complex inheritance: For many families, no single gene explains the condition. Instead, the risk may come from several genes acting together, which can help explain why relatives sometimes have different types of congenital heart defects.
Lifestyle risk factors
Tricuspid atresia is present from birth, so lifestyle habits do not cause it. Still, how lifestyle affects tricuspid atresia can be important because daily habits may influence exercise tolerance, fluid balance, heart strain, and the risk of complications after surgery or with long-term single-ventricle circulation. The most helpful focus is on habits that support heart function, avoid added stress on the circulation, and improve day-to-day symptom control.
Activity does not cause tricuspid atresia, but the right amount can help maintain stamina, muscle strength, and overall cardiovascular fitness. Too little movement can worsen deconditioning, while exertion beyond a cardiologist's guidance may increase breathlessness, dizziness, or fatigue.
High salt intake can promote fluid retention and make swelling or congestion harder to manage in people with tricuspid atresia. In those with heart failure symptoms or Fontan circulation, following individualized advice on sodium and fluid intake may reduce extra strain on the heart and circulation.
Excess body weight increases the work of breathing and the workload on the heart, which can worsen exercise intolerance. Maintaining a healthy weight may improve mobility, energy, and surgical or long-term cardiac outcomes.
Smoking and vaping can reduce oxygen delivery, irritate the lungs, and add stress to an already limited circulation. Avoiding tobacco exposure is one of the most important lifestyle risk factors for tricuspid atresia because lung health strongly affects how efficiently blood can be oxygenated.
Risk prevention
Tricuspid atresia usually cannot be prevented, and it often happens without a clear reason during early pregnancy. Many parents search for how to prevent tricuspid atresia, but the main goal is to lower the chance of some birth defects and, if a baby is born with tricuspid atresia, to reduce complications through early care. Prevention is about lowering risk, not eliminating it completely. Care before pregnancy, healthy pregnancy habits, and close heart follow-up after birth can all help.
Seeing a doctor before pregnancy can help review personal health, family history, and past pregnancies for factors linked with tricuspid atresia and other heart defects. This visit can also help optimize medicines and chronic conditions before conception.
Some medicines can raise the risk of birth defects if taken during pregnancy, so it is important to review all prescriptions, over-the-counter drugs, and supplements in advance. Do not stop a needed medicine on your own, but ask which options are safest when planning pregnancy.
Alcohol, smoking, vaping, and illicit drugs can increase the risk of serious pregnancy problems and may raise the chance of some heart defects. Avoiding these exposures before and during pregnancy is one of the clearest ways to lower preventable risk.
Good control of diabetes before conception and in early pregnancy is especially important because high blood sugar can increase the risk of congenital heart defects, including tricuspid atresia. Managing lupus, obesity, and seizure disorders carefully may also help lower risk.
Can you prevent Tricuspid atresia?
There is no sure way to prevent tricuspid atresia, and in many cases it happens for reasons no one could have predicted or controlled. Good care before and during pregnancy may help lower the risk of some birth defects, especially by managing diabetes, avoiding alcohol, smoking, and harmful medicines, and getting recommended vaccines before pregnancy. These steps support a healthy pregnancy, but they cannot guarantee that tricuspid atresia will be prevented.
Transmission
Tricuspid atresia is not infectious, so it cannot spread from one person to another. Instead, it develops before birth as the heart is forming, and when people ask about the genetic transmission of Tricuspid atresia, most cases appear to happen by chance with no clear family history.
In some families, Tricuspid atresia can be linked to a genetic change or to a broader genetic condition, which may raise the chance of another baby being born with a heart defect. If there is a family history of congenital heart disease, genetic counseling can help explain how Tricuspid atresia is inherited in your family and what that may mean for future pregnancies.
When to test your genes
For tricuspid atresia, genetic testing is usually considered when the heart defect appears with other birth differences, developmental delay, or a family history of congenital heart disease. It does not usually detect the condition earlier in the affected baby, but it can help look for an underlying syndrome, guide care, and inform future pregnancy planning.
Diagnosis
Many living with tricuspid atresia are diagnosed very early because a newborn may look blue, breathe fast, or tire with feeding within the first hours or days of life. Doctors usually begin with the baby’s symptoms, a physical exam, and oxygen levels, then confirm what they find with heart tests. Getting a diagnosis is often a turning point toward answers and support. In some babies, the diagnosis of tricuspid atresia is suspected before birth during a routine pregnancy ultrasound.
A doctor checks for bluish skin or lips, fast breathing, poor feeding, and signs that the heart is working hard. They also listen for heart murmurs and look for low oxygen levels that can point to a serious congenital heart problem.
This simple test measures how much oxygen is in the blood using a sensor placed on the skin. In tricuspid atresia, oxygen levels are often lower than expected because blood flow through the heart is abnormal.
This ultrasound of the heart is the main test used to confirm tricuspid atresia. It shows that the tricuspid valve did not form normally and helps doctors see blood flow, the size of the right ventricle, and any related heart defects.
This test records the heart’s electrical activity and may show patterns linked to strain or unusual heart structure. It does not confirm the condition by itself, but it adds useful details to the overall diagnosis of tricuspid atresia.
How is Tricuspid atresia diagnosed?
Tricuspid atresia is usually diagnosed with an ultrasound picture of the heart, called an echocardiogram, which shows that the valve between the right upper and lower heart chambers did not form normally and lets doctors see how blood is moving. It may first be suspected before birth on a pregnancy ultrasound, or after birth when a baby has blue-looking lips or skin, trouble feeding, fast breathing, or low oxygen levels on a simple skin sensor. Doctors may also use a heart tracing, a chest X-ray, or sometimes a thin tube test to look more closely at the heart, while genetic testing is not usually needed to confirm tricuspid atresia but may be offered if there are signs of another inherited condition.
Stages of Tricuspid atresia
Tricuspid atresia does not have defined progression stages. This is because it is a structural heart problem present from birth, rather than an illness that usually moves through step-by-step phases over time. Doctors usually start with a conversation about feeding, breathing, growth, and the early symptoms of tricuspid atresia, then confirm the diagnosis with tests such as pulse oximetry, an echocardiogram, and sometimes an electrocardiogram or chest X-ray. Ongoing care focuses on checking oxygen levels, growth, and heart function, and planning the right timing for treatment and follow-up.
Outlook and prognosis
Outlook for tricuspid atresia has improved markedly with staged surgical care, and many children now survive into adolescence and adulthood. Prognosis depends on associated heart defects, the size of the pulmonary blood flow, ventricular function, and whether complications develop before or after surgery. Without treatment, tricuspid atresia is often fatal in infancy or early childhood because of severe cyanosis, heart failure, or inadequate blood flow to the lungs. After palliative procedures and Fontan-type circulation, survival is much better, but lifelong follow-up is essential because later problems can include arrhythmias, blood clots, protein-losing enteropathy, liver disease, and eventual heart failure. Mortality remains higher than in the general population, especially in those with complex anatomy or failing Fontan circulation, yet many patients can attend school, work, and have a reasonable quality of life with specialized congenital heart care.
Long-term effects
Many living with tricuspid atresia can do well for years, especially after early heart surgery, but long-term health effects are still common and need watching over time. The long-term picture is often shaped by how well the heart pumps, how blood flows through the lungs and body, and whether later complications develop. As children with tricuspid atresia grow up, the long-term effects of tricuspid atresia in adults may include limits on stamina, heart rhythm problems, and strain on other organs. The outlook varies widely from one person to another.
Many people with tricuspid atresia tire more easily than their peers during sports, climbing stairs, or long walks. This can become more noticeable with age, even in people who felt fairly well in childhood.
In childhood, some may grow more slowly or gain weight less easily than expected. Later on, delayed puberty or a smaller body size than average can still be part of the long-term picture.
Abnormal heart rhythms can develop over time and may cause palpitations, dizziness, or fainting. These rhythm changes are more common after several heart procedures and can become a major part of adult care.
Over the years, the single working pumping chamber can become strained and less effective. For many, this can mean more fatigue, shortness of breath, swelling, or a reduced ability to keep up with daily activities.
How is it to live with Tricuspid atresia?
Living with tricuspid atresia often means planning daily life around energy, oxygen levels, medications, and regular visits with a heart specialist, because this condition affects how blood moves through the heart and lungs from birth. Many people with tricuspid atresia tire more easily, may need limits on intense physical activity, and some continue to need procedures or surgery follow-up as they grow, although day-to-day life can vary a lot depending on how well the heart is functioning after treatment. For families and other close supports, this can mean extra medical appointments, watching for symptoms like worsening shortness of breath or bluish skin, and adjusting school, work, travel, or exercise routines, but with good cardiac care many children and adults living with tricuspid atresia build full, meaningful lives.
Treatment and drugs
Tricuspid atresia is treated with a mix of medicines, careful monitoring, and heart procedures, because the right side of the heart did not form in the usual way and blood flow needs to be redirected. In the newborn period, some babies need a medicine that keeps a natural blood vessel open for a short time, while others may need oxygen, fluids, or medicines to help the heart pump and to manage extra fluid. Treatment plans often combine several approaches, and many children go on to have staged heart surgeries over time to improve blood flow to the lungs and body, with follow-up care that often includes medicines such as diuretics, drugs that support heart function, or blood thinners when needed. Not every treatment works the same way for every person, so care is tailored to the child’s heart anatomy, symptoms, growth, and oxygen levels.
Can you cure Tricuspid atresia?
No, tricuspid atresia cannot be fully cured because it is a heart problem present at birth in which one of the heart’s valves does not form normally. Treatment can still help a lot: babies and children usually need one or more heart surgeries, and some also need medicines, to improve blood flow and oxygen levels and help them grow and stay active. Many people living with tricuspid atresia do well for years after treatment, but they usually need lifelong heart checkups, and a few may later need a heart transplant.
Non-drug treatment
For many living with tricuspid atresia, care centers on procedures and daily support rather than medicines alone. Treatment usually happens in stages, often starting in infancy, to help blood reach the lungs and improve oxygen levels. Managing this condition often means regular follow-up over many years, because needs can change as a child grows.
The main non-drug treatment for tricuspid atresia is a series of heart operations that reroute blood flow. Many babies first need an early procedure to increase or balance blood flow, followed later by Glenn and Fontan surgery. This staged surgery for tricuspid atresia is planned around the child’s size, oxygen levels, and overall heart function.
Some children need catheter-based treatments, which use thin tubes passed through blood vessels instead of open-heart surgery. These procedures can open narrowed areas, place a stent, or close extra vessels that make circulation less efficient.
Babies with tricuspid atresia may tire easily during feeds, sweat while eating, or gain weight slowly. Feeding therapy and nutrition support can help them take in enough calories with less effort, and some may need temporary tube feeding.
Because long hospital stays and low oxygen levels can affect early milestones, some children benefit from physical, occupational, or speech therapy. Supportive therapies can build strength, feeding skills, coordination, and confidence with everyday activities.
Your genes may have an impact on how drugs work for you
People living with tricuspid atresia often take medicines to help the heart pump, control fluid buildup, prevent blood clots, or steady the heartbeat, and small inherited differences can sometimes affect how well these medicines work or how likely side effects are. For example, some may break down a medicine too quickly, so it does not help enough, while others may process it more slowly and be more likely to have problems like extra bleeding or stronger side effects. Right now, gene-based drug matching, sometimes called pharmacogenomics, is not a routine part of care for tricuspid atresia itself, but doctors may still use a person’s history, lab results, and response to treatment to choose the safest dose and medicine.
Pharmacological treatments
Medicines for tricuspid atresia do not correct the heart’s structure, but they can help blood flow, ease strain on the heart, and support a baby or child before and after procedures. Treatment depends a lot on age, oxygen levels, and whether there are signs of heart failure or poor circulation. Medication can feel like a big step, but in tricuspid atresia it is often used as part of a broader care plan that also includes surgery or catheter-based treatment. In newborns, some of the earliest treatment for tricuspid atresia is aimed at keeping blood moving to the lungs or body while doctors plan the next steps.
In newborns, prostaglandin E1 is often given through a vein to keep a blood vessel called the ductus arteriosus open. This can be lifesaving when a baby with tricuspid atresia needs that vessel to maintain blood flow to the lungs or the rest of the body.
Diuretics such as furosemide help the body get rid of extra fluid when the heart is working under strain. They may ease fast breathing, poor feeding, and swelling in babies or children with heart failure symptoms.
Medicines such as digoxin and sometimes ACE inhibitors like captopril or enalapril may be used when the heart is not pumping as effectively as needed. These drugs can help control symptoms and reduce workload on the heart, although they are not needed for everyone with tricuspid atresia.
Aspirin, heparin, warfarin, or sometimes other anticoagulants may be used after shunt surgery, after a Fontan procedure, or when there is concern about blood clots. The goal is to lower clot risk in altered blood flow pathways that can happen with tricuspid atresia.
Genetic influences
Genetics can play a role in tricuspid atresia because the heart forms very early in pregnancy, and that process depends on many genes working together. Most babies with tricuspid atresia are the first in their family to have it, but family history is one of the strongest clues to a genetic influence. If you already have a child or close relative with tricuspid atresia or another congenital heart defect, the chance of a future pregnancy being affected is usually still low, but it is higher than in the general population. In some families, the genetic causes of tricuspid atresia are part of a broader chromosome change or syndrome that can also affect other organs, so doctors may suggest genetic testing or meeting with a genetic counselor. For many living with tricuspid atresia, this information is less about finding one single cause and more about understanding recurrence risk, related health issues, and what testing may help guide care.
Is Tricuspid atresia genetic?
Genetics can play a role in tricuspid atresia, but most cases are not traced to a single inherited gene change. Rarely, genetic variations or chromosome differences are involved, especially when tricuspid atresia happens with other birth differences.
Having a genetic risk is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For babies living with tricuspid atresia, treatment usually centers on staged heart procedures, and any genetic findings can help the care team plan those steps more safely. If testing shows tricuspid atresia is part of a broader genetic condition, doctors may look more closely for related problems in the blood vessels, immune system, kidneys, or other organs that can affect when surgery happens and how closely medicines are monitored. Genetics is only one factor, and most medicines used with tricuspid atresia, such as drugs to support blood flow in newborns, remove extra fluid, prevent clots, or control heart rhythm, are still chosen mainly by age, oxygen levels, heart anatomy, and the stage of repair. At the moment, there is no routine gene test that directly tells doctors the best drug for tricuspid atresia in the way people sometimes hear about cancer treatment. Even so, a genetic diagnosis can help explain why one child has a more complex course than another and can guide follow-up after surgery. For families asking how genetics affect tricuspid atresia treatment, the main role of testing is to shape the overall care plan rather than to predict the exact effect of each medication.
Interactions with other conditions
People living with tricuspid atresia often need regular follow-up because this heart condition can affect, and be affected by, other health problems over time. Day-to-day, it can feel like one health issue amplifies the other, especially if heart rhythm problems, heart failure, or lung blood vessel changes develop after surgery or as the heart works harder than usual. Some may also have other congenital heart differences, such as a hole between the heart’s chambers or changes in blood flow to the lungs, and these can shape how symptoms show up and how treatment is planned. In some children and adults, tricuspid atresia can occur alongside genetic conditions or problems outside the heart, which may affect growth, feeding, exercise tolerance, or recovery from procedures. Because of this, early symptoms of worsening tricuspid atresia can sometimes overlap with signs of anemia, respiratory infections, or fluid buildup, making a careful medical review important. Ongoing care with a congenital heart specialist helps sort out which symptoms come from the heart itself and which may be linked to another condition.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Tricuspid atresia?
Other serious heart problems present at birth can look a lot like tricuspid atresia, especially pulmonary atresia, tetralogy of Fallot, and transposition of the great arteries, because they can also cause bluish skin or lips, fast breathing, trouble feeding, and poor weight gain. Doctors may also need to rule out severe lung disease or very high blood pressure in the lungs in a newborn, since these can also cause low oxygen levels, and a heart ultrasound usually helps tell the difference.
History
Long before modern heart scans existed, babies born with tricuspid atresia were recognized as having a serious heart problem, even if doctors did not yet understand exactly why. In day-to-day life, this often meant a newborn who looked bluish around the lips or tired easily with feeding, and families may have seen that something was wrong within the first hours or days after birth.
Early doctors described the visible effects rather than the heart’s internal structure. They could hear unusual heart sounds, notice poor growth, or see signs that the body was not getting enough oxygen, but they had limited tools to look inside the chest. As medical science evolved, tricuspid atresia became better understood as a condition present from birth in which one of the heart valves does not form normally, changing how blood moves through the heart and lungs.
A major turning point came in the 20th century, when advances in imaging, heart catheterization, and later echocardiography let doctors diagnose tricuspid atresia more accurately in living infants instead of relying mainly on findings after death. This helped explain why symptoms could vary. Some babies became very sick quickly, while others had a somewhat different course depending on the exact heart anatomy and how much blood was reaching the lungs.
Treatment history also changed dramatically. At first, care was mostly supportive, because there were few ways to correct complex heart defects. Over time, surgeons developed staged operations that could improve blood flow and help children survive into later childhood and adulthood. Not every early description was complete, yet together they built the foundation of today’s knowledge, including the careful planning now used for surgery, follow-up care, and monitoring over many years.
In recent decades, survival for people with tricuspid atresia has improved a great deal because of earlier diagnosis, safer heart surgery, better intensive care, and lifelong follow-up in congenital heart disease clinics. Knowing this history helps explain why early symptoms of tricuspid atresia are taken so seriously today and why ongoing specialist care remains such an important part of living well with the condition.